The University of Chicago Header Logo

Connection

Ryan Widau to Proportional Hazards Models

Back to Details
This is a "connection" page, showing publications Ryan Widau has written about Proportional Hazards Models.
Ryan Widau
Connection Strength
0.030
Proportional Hazards Models
  1. Ramucirumab plus docetaxel versus placebo plus docetaxel in patients with locally advanced or metastatic urothelial carcinoma after platinum-based therapy (RANGE): a randomised, double-blind, phase 3 trial. Lancet. 2017 Nov 18; 390(10109):2266-2277.
    View in: PubMed
    Score: 0.030
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.